Treatment with Optimal Dose Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Has a Positive Effect on Long-Term Survival in Older Individuals (Aged >70 Years) and Octogenarians with Systolic Heart Failure.

Luis Sargento,Andre Vicente Simões,Longo S,Nuno Lousada,Reis Rp

Treatment with Optimal Dose Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Has a Positive Effect on Long-Term Survival in Older Individuals (Aged >70 Years) and Octogenarians with Systolic Heart Failure.

2016

Luis Sargento
Andre Vicente Simões
Longo S
Nuno Lousada
Reis Rp

Background Heart failure with reduced ejection fraction (HFrEF) is a disease of older people, but the target doses of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers (ACEIs/ARBs) are unknown.

Keywords:

Diabetes mellitus
Disease
Ejection fraction
Angiotensin-converting enzyme
Heart failure
Angiotensin Receptor Blockers
Internal medicine
Medicine
Cardiology
Pharmacotherapy
long term survival

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations